Will the launch of Favipiravir mark the turnaround for Glenmark Pharma?

If the drug proves to be efficacious for Covid treatment, Glenmark will enjoy first mover advantage.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3fL0WUm
via IFTTT